≪英文≫

Cancer cells release anaphylatoxin C5a from C5 by serine protease to enhance invasiveness.

Nitta H, Murakami Y, Wada Y, Eto M, Baba H, Imamura T.

Oncol Rep. 2014 Oct;32(4):1715-9.

The effect of ABCG2 genotype on the population pharmacokinetics of sunitinib in patients with renal cell carcinoma.

Mizuno T, Fukudo M, Fukuda T, Terada T, Dong M, Kamba T, Yamasaki T, Ogawa O, Katsura T, Inui K, Vinks AA, Matsubara K.

Ther Drug Monit. 2014 Jun;36(3):310-6.

Risk factors for loss to follow-up during active surveillance of patients with Stage I seminoma.

Endo T, Kawai K, Kamba T, Inai H, Uchida K, Miyazaki J, Kamoto T, Ogawa O, Nishiyama H.

Jpn J Clin Oncol. 2014 Apr;44(4):355-9.

Improvement of prognosis in patients with metastatic renal cell carcinoma and Memorial Sloan-Kettering Cancer Center intermediate risk features by modern strategy including molecular-targeted therapy in clinical practice.

Kamba T, Yamasaki T, Teramukai S, Shibasaki N, Arakaki R, Sakamoto H, Matsui Y, Okubo K, Yoshimura K, Ogawa O.

Int J Clin Oncol. 2014;19(3):505-15.